Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000121949 | SCV000226779 | benign | not specified | 2015-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000230976 | SCV000288257 | benign | Baller-Gerold syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001596972 | SCV001830925 | likely benign | not provided | 2020-11-02 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000121949 | SCV002071464 | likely benign | not specified | 2021-10-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001596972 | SCV003917639 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | RECQL4: BP4, BS1 |
KCCC/NGS Laboratory, |
RCV003315769 | SCV004017288 | benign | Rothmund-Thomson syndrome type 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001596972 | SCV005222946 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000121949 | SCV000086156 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Prevention |
RCV004542912 | SCV004768309 | benign | RECQL4-related disorder | 2019-03-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |